Skip to main content

Daniel Christopher Parker

Associate Professor of Medicine
Medicine, Geriatrics and Palliative Care
Rm 1510 Blue Zone Duke South, Box 3003, Durham, NC 27705

Overview


My clinical and research interests center on the development and use of disease-modifying treatments for Alzheimer's disease and related dementias (ADRD). I am a regional leader in the use of amyloid targeted therapies (ATT), including lecanemab and donanemab, for the treatment of early Alzheimer's disease. I serve as director of the Duke Memory Disorders Clinic.

Current Appointments & Affiliations


Associate Professor of Medicine · 2025 - Present Medicine, Geriatrics and Palliative Care, Medicine
Associate Professor in Neurology · 2025 - Present Neurology, Behavioral Neurology, Neurology
Senior Fellow of the Center for the Study of Aging and Human Development · 2020 - Present Center for the Study of Aging and Human Development, Institutes and Centers

In the News


Published July 31, 2023
MURDOCK Study Points to Key Pathway in Development of Alzheimer’s Disease

View All News

Recent Publications


Correlating retinal and choroidal vascular parameters with volumetric MRI in Alzheimer's disease and amnestic mild cognitive impairment.

Journal Article BMC Ophthalmol · July 1, 2025 BACKGROUND: We assess the relationships between retinal and choroidal structural and microvascular parameters and brain volumetric magnetic resonance imaging (MRI) parameters in individuals with amnestic mild cognitive impairment (aMCI) and Alzheimer's dis ... Full text Link to item Cite

LXR signaling pathways link cholesterol metabolism with risk for prediabetes and diabetes.

Journal Article J Clin Invest · May 15, 2024 BACKGROUNDPreclinical studies suggest that cholesterol accumulation leads to insulin resistance. We previously reported that alterations in a monocyte cholesterol metabolism transcriptional network (CMTN) - suggestive of cellular cholesterol accumulation - ... Full text Link to item Cite
View All Publications

Recent Grants


Skeletal Muscle Molecular Drug Targets for Exercise-induced Cardiometabolic Health

ResearchCo Investigator · Awarded by National Heart, Lung, and Blood Institute · 2021 - 2026

Physical Resiliencies: Indicators and Mechanisms in the Elderly Collaborative (PRIME Collaborative)

ResearchCo Investigator · Awarded by National Institutes of Health · 2017 - 2024

Epigenetic Mechanisms Promoting Longevity

ResearchData Manager · Awarded by National Institutes of Health · 2018 - 2024

View All Grants

Education, Training & Certifications


Eastern Virginia Medical School · 2013 M.D.

External Links


ORCID Page